Indian Journal of Sleep Medicine

Register      Login

VOLUME 8 , ISSUE 1 ( January-March, 2013 ) > List of Articles

REVIEW ARTICLE

Restless legs syndrome

Neetu Jain, Gopi C Khilnani

Keywords : Restless legs, RLS, sleep disorders, Willis Ekbom Syndrome

Citation Information : Jain N, Khilnani GC. Restless legs syndrome. Indian Sleep Med 2013; 8 (1):1-11.

DOI: 10.5958/j.0974-0155.8.1.001

License: CC BY-SA 4.0

Published Online: 01-03-2013

Copyright Statement:  Copyright © 2013; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Sleep is essential to maintain quality of life. Restless legs syndrome (RLS) is a disorder which is characterized by uncomfortable feeling in legs, irresistible urge to move them and compromised sleep quality. It is a common problem but is usually under diagnosed or misdiagnosed. It can be easily diagnosed by using criteria proposed by International Restless Legs Society. Though no specific investigations are require for diagnosis, investigations are required to discern the cause. Treatment of the cause relieves the symptoms of secondary RLS. In case of primary RLS most patients improve with non-pharmacological treatment. Those who require drug treatment should be classified as per frequency and severity of symptoms. Dopamine agonists are first line drugs, however, the treatment needs to be individualized depending upon the symptoms of the patients. This review aims at comprehensive overview of RLS including diagnosis and management.


PDF Share
  1. Morin CM, LeBlanc M, Belanger L, Ivers H, Merette C, Savard J. Prevalence of insomnia and its treatment in Canada. Can J Psychiatry. Sep;56 :540-8.
  2. Roth T, Coulouvrat C, Hajak G, Lakoma MD, Sampson NA, Shahly V, et al. Prevalence and perceived health associated with insomnia based on DSM-IV-TR; International Statistical Classification of Diseases and Related Health Problems, Tenth Revision; and Research Diagnostic Criteria/ International Classification of Sleep Disorders, Second Edition criteria: results from the America Insomnia Survey. Biol Psychiatry. Mar 15;69 :592-600.
  3. Walsh JK, Coulouvrat C, Hajak G, Lakoma MD, Petukhova M, Roth T, et al. Nighttime insomnia symptoms and perceived health in the America Insomnia Survey (AIS). Sleep. Aug;34 :997-1011.
  4. Winkelman JW, Redline S, Baldwin CM, Resnick HE, Newman AB, Gottlieb DJ. Polysomnographic and healthrelated quality of life correlates of restless legs syndrome in the Sleep Heart Health Study. Sleep. 2009 Jun;32 :772-8.
  5. Allen RP, Walters AS, Montplaisir J, Hening W, Myers A, Bell TJ, et al. Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med. 2005 Jun 13;165:1286-92.
  6. Happe S, Reese JP, Stiasny-Kolster K, Peglau I, Mayer G, Klotsche J, et al. Assessing health-related quality of life in patients with restless legs syndrome. Sleep Med. 2009 Mar;10:295-305.
  7. Walters AS, Rye DB. Review of the relationship of restless legs syndrome and periodic limb movements in sleep to hypertension, heart disease, and stroke. Sleep. 2009 May;32 :589-97.
  8. Innes KE, Selfe TK, Agarwal P. Restless legs syndrome and conditions associated with metabolic dysregulation, sympathoadrenal dysfunction, and cardiovascular disease risk: a systematic review. Sleep Med Rev. Aug;16:309-39.
  9. Coccagna G, Vetrugno R, Lombardi C, Provini F. Restless legs syndrome: an historical note. Sleep Med. 2004 May;5 :279-83.
  10. Ekbom KA. Restless legs; a report of 70 new cases. Acta Med Scand Suppl. 1950;246:64-8.
  11. Walters AS. Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group. Mov Disord. 1995 Sep;10 :634-42.
  12. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med. 2003 Mar;4:101-19.
  13. Hening W, Walters AS, Allen RP, Montplaisir J, Myers A, Ferini-Strambi L. Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study. Sleep Med. 2004 May;5:237-46.
  14. Rangarajan S, Rangarajan S, D'Souza GA. Restless legs syndrome in an Indian urban population. Sleep Med. 2007 Dec;9 :88-93.
  15. Vogl FD, Pichler I, Adel S, Pinggera GK, Bracco S, De Grandi A, et al. Restless legs syndrome: epidemiological and clinicogenetic study in a South Tyrolean population isolate. Mov Disord. 2006 Aug;21:1189-95.
  16. Allen RP, Earley CJ. Restless legs syndrome: a review of clinical and pathophysiologic features. J Clin Neurophysiol. 2001 Mar;18 :128-47.
  17. Ohayon MM, O'Hara R, Vitiello MV. Epidemiology of restless legs syndrome: a synthesis of the literature. Sleep Med Rev. Aug;16 :283-95.
  18. Rothdach AJ, Trenkwalder C, Haberstock J, Keil U, Berger K. Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and Morbidity in Augsburg Elderly. Neurology. 2000 Mar 14;54 :1064-8.
  19. Krishnan PR, Bhatia M, Behari M. Restless legs syndrome in Parkinson's disease: a case-controlled study. Mov Disord. 2003 Feb;18 :181-5.
  20. Gupta R, Lahan V, Goel D. Restless Legs Syndrome: a common disorder, but rarely diagnosed and barely treated— an Indian experience. Sleep Med. Aug;13 :838-41.
  21. Picchietti D, Allen RP, Walters AS, Davidson JE, Myers A, Ferini-Strambi L. Restless legs syndrome: prevalence and impact in children and adolescents—the Peds REST study. Pediatrics. 2007 Aug;120 :253-66.
  22. Montplaisir J, Boucher S, Poirier G, Lavigne G, Lapierre O, Lesperance P. Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. 1997 Jan;12 :61-5.
  23. Cesnik E, Casetta I, Turri M, Govoni V, Granieri E, Strambi LF, et al. Transient RLS during pregnancy is a risk factor for the chronic idiopathic form. Neurology. Dec 7;75:2117- 20.
  24. Salas RE, Gamaldo CE, Allen RP. Update in restless legs syndrome. Curr Opin Neurol. Aug;23 :401-6.
  25. Allen RP, Earley CJ. The role of iron in restless legs syndrome. Mov Disord. 2007;22 Suppl 18:S440-8.
  26. Connor JR, Boyer PJ, Menzies SL, Dellinger B, Allen RP, Ondo WG, et al. Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology. 2003 Aug 12;61:304-9.
  27. Winkelmann J, Polo O, Provini F, Nevsimalova S, Kemlink D, Sonka K, et al. Genetics of restless legs syndrome (RLS): State-of-the-art and future directions. Mov Disord. 2007;22 Suppl 18:S449-58.
  28. Winkelmann J, Schormair B, Lichtner P, Ripke S, Xiong L, Jalilzadeh S, et al. Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat Genet. 2007 Aug;39:1000-6.
  29. Stefansson H, Rye DB, Hicks A, Petursson H, Ingason A, Thorgeirsson TE, et al. A genetic risk factor for periodic limb movements in sleep. N Engl J Med. 2007 Aug 16;357 :639-47.
  30. Rijsman RM, de Weerd AW, Stam CJ, Kerkhof GA, Rosman JB. Periodic limb movement disorder and restless legs syndrome in dialysis patients. Nephrology (Carlton). 2004 Dec;9 :353-61.
  31. Winkelmann J, Stautner A, Samtleben W, Trenkwalder C. Long-term course of restless legs syndrome in dialysis patients after kidney transplantation. Mov Disord. 2002 Sep;17:1072-6.
  32. Winkelman JW, Chertow GM, Lazarus JM. Restless legs syndrome in end-stage renal disease. Am J Kidney Dis. 1996 Sep;28 :372-8.
  33. Bhowmik D, Bhatia M, Tiwari S, Mahajan S, Gupta S, Agarwal SK, et al. Low prevalence of restless legs syndrome in patients with advanced chronic renal failure in the Indian population: a case controlled study. Ren Fail. 2004 Jan;26: 69-72.
  34. Lin CH, Wu VC, Li WY, Sy HN, Wu SL, Chang CC, et al. Restless legs syndrome in end-stage renal disease: a multicenter study in Taiwan. Eur J Neurol. Feb 1.
  35. Zilberman M, Silverberg DS, Schwartz D, Oksenberg A. Restless legs syndrome (RLS) in anemic patients with congestive heart failure and chronic renal failure: lack of effect of anemia treatment. Int J Cardiol. Aug 20;143:205- 7.
  36. Gemignani F, Brindani F, Negrotti A, Vitetta F, Alfieri S, Marbini A. Restless legs syndrome and polyneuropathy. Mov Disord. 2006 Aug;21 :1254-7.
  37. Taylor-Gjevre RM, Gjevre JA, Skomro R, Nair B. Restless legs syndrome in a rheumatoid arthritis patient cohort. J Clin Rheumatol. 2009 Feb;15 :12-5.
  38. Trenkwalder C, Hening WA, Montagna P, Oertel WH, Allen RP, Walters AS, et al. Treatment of restless legs syndrome: an evidence-based review and implications for clinical practice. Mov Disord. 2008 Dec 15;23 :2267-302.
  39. Vignatelli L, Billiard M, Clarenbach P, Garcia-Borreguero D, Kaynak D, Liesiene V, et al. EFNS guidelines on management of restless legs syndrome and periodic limb movement disorder in sleep. Eur J Neurol. 2006 Oct;13 :1049-65.
  40. Garcia-Borreguero D, Allen R, Kohnen R, Benes H, Winkelman J, Hogl B, et al. Loss of response during longterm treatment of restless legs syndrome: guidelines approved by the International Restless Legs Syndrome Study Group for use in clinical trials. Sleep Med. Oct;11 :956-7.
  41. Aurora RN, Kristo DA, Bista SR, Rowley JA, Zak RS, Casey KR, et al. The treatment of restless legs syndrome and periodic limb movement disorder in adults-an update for 2012: practice parameters with an evidence-based systematic review and meta-analyses: an American Academy of Sleep Medicine Clinical Practice Guideline. Sleep. Aug;35:1039-62.
  42. Aukerman MM, Aukerman D, Bayard M, Tudiver F, Thorp L, Bailey B. Exercise and restless legs syndrome: a randomized controlled trial. J Am Board Fam Med. 2006 Sep-Oct;19 :487-93.
  43. Lakasing E. Exercise beneficial for restless legs syndrome. Practitioner. 2008 May;252 :43-5.
  44. Byrne R, Sinha S, Chaudhuri KR. Restless legs syndrome: diagnosis and review of management options. Neuropsychiatr Dis Treat. 2006 Jun;2 :155-64.
  45. Akpinar S. Treatment of restless legs syndrome with levodopa plus benserazide. Arch Neurol. 1982 Nov;39 :739.
  46. Montplaisir J, Godbout R, Poirier G, Bedard MA. Restless legs syndrome and periodic movements in sleep: physiopathology and treatment with L-dopa. Clin Neuropharmacol. 1986;9 :456-63.
  47. Hening WA, Allen RP, Earley CJ, Picchietti DL, Silber MH. An update on the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. Sleep. 2004 May 1;27 :560-83.
  48. Hening W, Allen R, Earley C, Kushida C, Picchietti D, Silber M. The treatment of restless legs syndrome and periodic limb movement disorder. An American Academy of Sleep Medicine Review. Sleep. 1999 Nov 1;22 :970-99.
  49. Trenkwalder C, Collado Seidel V, Kazenwadel J, Wetter TC, Oertel W, Selzer R, et al. One-year treatment with standard and sustained-release levodopa: appropriate longterm treatment of restless legs syndrome? Mov Disord. 2003 Oct;18 :1184-9.
  50. Hogl B, Oertel WH, Stiasny-Kolster K, Geisler P, Benes H, Garcia-Borreguero D, et al. Treatment of moderate to severe restless legs syndrome: 2-year safety and efficacy of rotigotine transdermal patch. BMC Neurol.10:86.
  51. Hening WA, Allen RP, Ondo WG, Walters AS, Winkelman JW, Becker P, et al. Rotigotine improves restless legs syndrome: a 6-month randomized, double-blind, placebocontrolled trial in the United States. Mov Disord. Aug 15;25 :1675-83.
  52. Oertel WH, Benes H, Garcia-Borreguero D, Geisler P, Hogl B, Trenkwalder C, et al. One year open-label safety and efficacy trial with rotigotine transdermal patch in moderate to severe idiopathic restless legs syndrome. Sleep Med. 2008 Dec;9 :865-73.
  53. Oertel WH, Benes H, Garcia-Borreguero D, Geisler P, Hogl B, Saletu B, et al. Efficacy of rotigotine transdermal system in severe restless legs syndrome: a randomized, doubleblind, placebo-controlled, six-week dose-finding trial in Europe. Sleep Med. 2008 Mar;9 :228-39.
  54. Stiasny-Kolster K, Kohnen R, Schollmayer E, Moller JC, Oertel WH. Patch application of the dopamine agonist rotigotine to patients with moderate to advanced stages of restless legs syndrome: a double-blind, placebo-controlled pilot study. Mov Disord. 2004 Dec;19 :1432-8.
  55. Kushida CA, Walters AS, Becker P, Thein SG, Perkins AT, Roth T, et al. A randomized, double-blind, placebo-controlled, crossover study of XP13512/GSK1838262 in the treatment of patients with primary restless legs syndrome. Sleep. 2009 Feb;32:159-68.
  56. Walters AS, Ondo WG, Kushida CA, Becker PM, Ellenbogen AL, Canafax DM, et al. Gabapentin enacarbil in restless legs syndrome: a phase 2b, 2-week, randomized, doubleblind, placebo-controlled trial. Clin Neuropharmacol. 2009 Nov-Dec;32 :311-20.
  57. Lee DO, Ziman RB, Perkins AT, Poceta JS, Walters AS, Barrett RW. A randomized, double-blind, placebo-controlled study to assess the efficacy and tolerability of gabapentin enacarbil in subjects with restless legs syndrome. J Clin Sleep Med. Jun 15;7 :282-92.
  58. Winkelman JW, Bogan RK, Schmidt MH, Hudson JD, De Rossett SE, Hill-Zabala CE. Randomized polysomnography study of gabapentin enacarbil in subjects with restless legs syndrome. Mov Disord. Sep;26:2065-72.
  59. Garcia-Borreguero D, Larrosa O, de la Llave Y, Verger K, Masramon X, Hernandez G. Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study. Neurology. 2002 Nov 26;59 :1573-9.
  60. Garcia-Borreguero D, Larrosa O, Williams AM, Albares J, Pascual M, Palacios JC, et al. Treatment of restless legs syndrome with pregabalin: a double-blind, placebocontrolled study. Neurology. Jun 8;74 :1897-904.
  61. Wagner ML, Walters AS, Coleman RG, Hening WA, Grasing K, Chokroverty S. Randomized, double-blind, placebocontrolled study of clonidine in restless legs syndrome. Sleep. 1996 Jan;19 :52-8.
  62. Ausserwinkler M, Schmidt P. [Successful clonidine treatment of restless leg syndrome in chronic kidney insufficiency]. Schweiz Med Wochenschr. 1989 Feb 11;119 :184-6.
  63. Walters AS, Wagner ML, Hening WA, Grasing K, Mills R, Chokroverty S, et al. Successful treatment of the idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone versus placebo. Sleep.1993 Jun;16:327-32.
  64. Boghen D, Lamothe L, Elie R, Godbout R, Montplaisir J. The treatment of the restless legs syndrome with clonazepam: a prospective controlled study. Can J Neurol Sci. 1986 Aug;13 :245-7.
  65. Shinno H, Oka Y, Otsuki M, Tsuchiya S, Mizuno S, Kawada S, et al. Proposed dose equivalence between clonazepam and pramipexole in patients with restless legs syndrome. Prog Neuropsychopharmacol Biol Psychiatry. Apr 16;34:522-6.
  66. Leschziner G, Gringras P. Restless legs syndrome. Bmj.344:e3056.
  67. Benz RL, Pressman MR, Hovick ET, Peterson DD. A preliminary study of the effects of correction of anemia with recombinant human erythropoietin therapy on sleep, sleep disorders, and daytime sleepiness in hemodialysis patients (The SLEEPO study). Am J Kidney Dis. 1999 Dec;34:1089-95.
  68. Collado-Seidel V, Kohnen R, Samtleben W, Hillebrand GF, Oertel WH, Trenkwalder C. Clinical and biochemical findings in uremic patients with and without restless legs syndrome. Am J Kidney Dis. 1998 Feb;31:324-8.
  69. Lee KA, Zaffke ME, Baratte-Beebe K. Restless legs syndrome and sleep disturbance during pregnancy: the role of folate and iron. J Womens Health Gend Based Med. 2001 May;10 :335-41.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.